相关实验视频

Updated: Jun 22, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

[18F]FDG PET/CT成像显示乳腺癌导致的多胞性脚缩成形

Hangyu Xie¹, Liu Xiao², Lin Li²

¹Department of Nuclear Medicine, West China Hospital of Sichuan University, China. 15699658339@163.com.

Nuclear medicine review. Central & Eastern Europe

|July 5, 2024

概括

甲状腺扩散,或癌症扩散到脚骨,是非常罕见的. 本案例研究详细介绍了一名患有转移性乳腺癌的女性,其表现为脚部的多转移性转移.

科学领域:

在瘤学瘤学.
放射学放射学是一门学科.
病理学病理学病理学

背景情况:

甲基转移并不常见,脚骨转移发生在不到0.01%的患者中.
脚部的多胞性转移 (多个部位) 是非常罕见的.
转移性疾病需要准确的诊断和表征,以进行适当的患者管理.

研究的目的:

报告一种极为罕见的,由于乳腺癌而导致的足部多胞性转移的病例.
为了突出[18F]FDG PET/CT和活检在识别形转移时的诊断效用.
为在瘤学中对罕见转移性呈现的文献做出贡献.

主要方法:

一个50岁的女性患者的病例报告,她有极端右翼乳房切除的病史.
右脚逐渐疼痛和胀的临床表现.
[18F]FDG PET/CT成像和CT引导的骨活检用于诊断.

主要成果:

[18F]FDG PET/CT揭示了右脚多个具有高代谢活性的骨破坏区域.
在CT指导的骨活检中,证实了转移性乳腺癌.
这些发现代表了一种极为罕见的多位性甲状腺扩散病例.

结论:

转移性乳腺癌可以呈现为足部罕见的形转移.
像[18F]FDG PET/CT这样的先进成像对于检测和表征这种罕见的转移性病变至关重要.
活检确认对于在不同寻常的位置确诊转移性疾病至关重要.

关键词:

[18F]FDG PET/CT PET/CT PET/CT [18F]FDG PET/CT PET/CT/CT [18F]FDG PET/CT PET/CT/CT [18F]FDG PET/CT/CT 这就是Acrometastases.乳腺癌,乳腺癌.

更多相关视频

Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound

Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound

Published on: August 14, 2012

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...